These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 14980680)
1. Syntheses and biological evaluation of new fluoroquinolone antibacterials containing chiral oxiimino pyrrolidine. Choi DR; Shin JH; Yang J; Yoon SH; Jung YH Bioorg Med Chem Lett; 2004 Mar; 14(5):1273-7. PubMed ID: 14980680 [TBL] [Abstract][Full Text] [Related]
2. Synthesis and antibacterial activity of novel fluoroquinolones containing substituted piperidines. Dang Z; Yang Y; Ji R; Zhang S Bioorg Med Chem Lett; 2007 Aug; 17(16):4523-6. PubMed ID: 17566733 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antibacterial activity of fluoroquinolone derivatives containing 3-(N'-alkoxycarbamimidoyl)-4-(alkoxyimino) pyrrolidines. Guo Q; Feng LS; Liu ML; Zhang YB; Chai Y; Lv K; Guo HY; Han LY Eur J Med Chem; 2010 Nov; 45(11):5498-506. PubMed ID: 20833454 [TBL] [Abstract][Full Text] [Related]
4. The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents. Murphy ST; Case HL; Ellsworth E; Hagen S; Huband M; Joannides T; Limberakis C; Marotti KR; Ottolini AM; Rauckhorst M; Starr J; Stier M; Taylor C; Zhu T; Blaser A; Denny WA; Lu GL; Smaill JB; Rivault F Bioorg Med Chem Lett; 2007 Apr; 17(8):2150-5. PubMed ID: 17303420 [TBL] [Abstract][Full Text] [Related]
5. The synthesis and biological evaluation of a novel series of C7 non-basic substituted fluoroquinolones as antibacterial agents. Huang X; Chen D; Wu N; Zhang A; Jia Z; Li X Bioorg Med Chem Lett; 2009 Aug; 19(15):4130-3. PubMed ID: 19539467 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and antibacterial evaluation of 1beta-methyl-2-(5-substituted heterocyclic carbamoyl)pyrrolidin-3-ylthio)carbapenem derivatives. Lee JS; Choa JH; Cho H; Oh CH Arch Pharm (Weinheim); 2004 Jul; 337(7):391-7. PubMed ID: 15237389 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and antibacterial activity of new fluoroquinolones containing a substituted N-(phenethyl)piperazine moiety. Foroumadi A; Ghodsi S; Emami S; Najjari S; Samadi N; Faramarzi MA; Beikmohammadi L; Shirazi FH; Shafiee A Bioorg Med Chem Lett; 2006 Jul; 16(13):3499-503. PubMed ID: 16644219 [TBL] [Abstract][Full Text] [Related]
8. [Synthesis and antibacterial activities of 7-{4-[2-[2-substituted-4-((5S)-5-acetylaminomethyl-2-oxo-oxazolidin-3-yl)}-phenyl] -ethyl]-piperazin-1-yl}-fluoroquinolones]. Yu HJ; Zhou WC Yao Xue Xue Bao; 2006 Oct; 41(10):990-9. PubMed ID: 17184119 [TBL] [Abstract][Full Text] [Related]
9. Synthesis and antibacterial activity of novel pyrido[1,2,3-de][1,4]benzoxazine-6-carboxylic acid derivatives carrying the 3-cyclopropylaminomethyl-4-substituted-1-pyrrolidinyl group as a C-10 substituent. Asahina Y; Takei M; Kimura T; Fukuda Y J Med Chem; 2008 Jun; 51(11):3238-49. PubMed ID: 18457383 [TBL] [Abstract][Full Text] [Related]
10. Phenothiazinium-fluoroquinolone drug conjugates. Wainwright M; Shah A; Meegan K; Loughran C; Smith A; Valli N; Dempster N Int J Antimicrob Agents; 2010 Apr; 35(4):405-9. PubMed ID: 20060690 [TBL] [Abstract][Full Text] [Related]
11. Synthesis and in-vitro activity of new 1beta-methylcarbapenem derivatives as antibacterial agents. Jung MH; Hong JH; Cho JH; Oh CH Arch Pharm (Weinheim); 2008 Dec; 341(12):780-6. PubMed ID: 19009543 [TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of 1beta-methylcarbapenems having guanidino moieties. Oh CH; Cho JH Eur J Med Chem; 2006 Jan; 41(1):50-5. PubMed ID: 16260069 [TBL] [Abstract][Full Text] [Related]
13. A chiral benzoquinolizine-2-carboxylic acid arginine salt active against vancomycin-resistant Staphylococcus aureus. de Souza NJ; Gupte SV; Deshpande PK; Desai VN; Bhawsar SB; Yeole RD; Shukla MC; Strahilevitz J; Hooper DC; Bozdogan B; Appelbaum PC; Jacobs MR; Shetty N; Patel MV; Jha R; Khorakiwala HF J Med Chem; 2005 Aug; 48(16):5232-42. PubMed ID: 16078842 [TBL] [Abstract][Full Text] [Related]
14. Novel lbeta-methylcarbapenems having cyclic sulfonamide moieties: synthesis and evaluation of in vitro antibacterial activity. Kim SJ; Park HB; Lee JS; Jo NH; Yoo KH; Baek D; Kang BW; Cho JH; Oh CH Eur J Med Chem; 2007 Sep; 42(9):1176-83. PubMed ID: 17418453 [TBL] [Abstract][Full Text] [Related]
15. Synthesis and in vitro antibacterial activity of 7-(4-alkoxyimino-3-amino-3-methylpiperidin-1-yl)fluoroquinolone derivatives. Chai Y; Wan ZL; Wang B; Guo HY; Liu ML Eur J Med Chem; 2009 Oct; 44(10):4063-9. PubMed ID: 19481308 [TBL] [Abstract][Full Text] [Related]
16. Acetylene compounds of potential pharmacological value. XXVII. Stereoselectivity of oxotremorine antagonists containing a chiral pyrrolidine group. Ringdahl B; Dahlbom R Acta Pharm Suec; 1978; 15(4):255-63. PubMed ID: 726907 [No Abstract] [Full Text] [Related]
17. Synthesis, antimycobacterial and antibacterial activity of l-[(1R,2S)-2-fluorocyclopropyl]naphthyridone derivatives containing an oxime-functionalized pyrrolidine moiety. Huang J; Liu H; Liu M; Zhang R; Li L; Wang B; Wang M; Wang C; Lu Y Bioorg Med Chem Lett; 2015 Nov; 25(22):5058-63. PubMed ID: 26476970 [TBL] [Abstract][Full Text] [Related]
18. Novel 1beta-methylcarbapenems with isoxazoloethenyl moieties containing carboxylic acid sodium salt. Lee KS; Kang YK; Yoo KH; Kim DC; Shin KJ; Paik YS; Kim DJ Bioorg Med Chem Lett; 2005 Jan; 15(1):231-4. PubMed ID: 15582445 [TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro activity of a series 1beta-methylcarbapenem derivatives. Jeon HC; Kim JW; Hong JH; Cho JH; Oh CH Eur J Med Chem; 2006 Oct; 41(10):1201-9. PubMed ID: 16797791 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]